Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neuroblastoma × Immunoglobulin G × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 9 Lung Neoplasms 7 Fallopian Tube Neoplasms 7 Ovarian Neoplasms 5 Colorectal Neoplasms 4 Urinary Bladder Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Glioblastoma 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Brain Neoplasms 3 Urethral Neoplasms 2 Ureteral Neoplasms 2 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoid Interstitial Pneumonia 2 Colonic Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Renal Cell 2 Carcinoma, Neuroendocrine 2 Carcinoma 2 Brenner Tumor 2 Adenocarcinoma, Mucinous 2 Urologic Neoplasms 1

Interventions

Cyclophosphamide 11 Magnetic Resonance Spectroscopy 8 dinutuximab 6 Topotecan 6 Temozolomide 6 Irinotecan 6 Biopsy 6 X-Rays 5 Specimen Handling 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 sargramostim 3 Isotretinoin 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Etoposide 3 Colony-Stimulating Factors 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 pembrolizumab 2 palbociclib 2 naxitamab 2 larotrectinib 2 ivosidenib 2 fludarabine phosphate 2 fludarabine 2 erdafitinib 2 ensartinib 2 Nivolumab 2 Doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02914405 2025-10-22

MiniVan

University Hospital Southampton NHS Foundation Trust

Phase 1 Active not recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡